China's Wuxi PharmaTech Signs New Agreement On Toxicology Studies Training And Services With J&J Unit

BEIJING - Just days after disclosing that a newly launched drug safety testing center had been accredited by a U.S. group, leading Chinese contract research organization Wuxi PharmaTech signed a toxicology deal with Johnson & Johnson Pharmaceutical Research & Development

More from Archive

More from Scrip